Stamm Biotech

Stamm Biotech

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5.5M

Overview

Stamm Biotech is a private, pre-revenue biotech platform company focused on transforming biomanufacturing for biologics and cell therapies through automation, continuous processing, and artificial intelligence. Its core offerings include a proprietary High-throughput Bioprocessor for production, end-to-end bioengineering services for cell line development, and a Bio AI platform called MoNA for predictive cell modeling. By integrating engineering and data science, Stamm aims to make bioprocesses more scalable, efficient, and sustainable, primarily serving the research and development needs of partners in the life sciences industry.

OncologyImmunology

Technology Platform

Integrated platform combining a High-throughput Bioprocessor for automated continuous biomanufacturing, bioengineering services for cell line development, and the MoNA AI platform for predictive cell modeling using multi-omic data.

Funding History

1
Total raised:$5.5M
Seed$5.5M

Opportunities

The global biomanufacturing market, especially for complex biologics and cell therapies, is large and growing rapidly, with a significant need for more efficient, scalable, and cost-effective production technologies.
Stamm's integrated AI and hardware platform addresses this core bottleneck and aligns with trends towards automation, continuous processing, and data-driven bioprocessing.

Risk Factors

Key risks include technology validation at commercial scale, competition from large established players and other startups, and financial dependency on external funding as a pre-revenue company.
Successfully convincing the conservative biopharma industry to adopt a new manufacturing paradigm is a major adoption hurdle.

Competitive Landscape

Stamm competes in the bioprocessing equipment and services market against large conglomerates like Sartorius, Thermo Fisher, and Danaher, as well as other innovators in continuous processing and AI for biomanufacturing. Its differentiation lies in the tight integration of a proprietary continuous bioprocessor with a generative AI platform designed specifically for cell behavior prediction and process optimization.